Barton P. Bandy, President and CEO at ReShape Lifesciences Inc. (RSLS), sold 7,150 shares at $1.79 ($13K) on 2022-01-04, disclosed to the SEC on 2022-01-28.
Open-market sale of $13k RSLS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RSLS | SELL | 2022-06-06 | $11K | — | Filing → |
| RSLS | SELL | 2022-05-12 | $9K | — | Filing → |
| RSLS | SELL | 2022-04-08 | $13K | — | Filing → |